1-3 of 3
Mark Lustberg
Close
Sort by
Journal Articles

Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease

Haley L. Klimaszewski, Christoph Weigel, Selamawit Addissie, Sarah Schlotter, Tounkara Fode, James P. Dugan, Bradley M. Haverkos, Lynda Villagomez, Mark Lustberg, Pierluigi Porcu, Timothy Voorhees, Michael A Caligiuri, Christopher C. Oakes, Ginny Bumgardner, Robert Baiocchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4476.
https://doi.org/10.1182/blood-2023-189618
Published: 2023
Journal Articles

Methylome Analysis of Epstein-Barr Virus with Nanopore Sequencing Reveals Viral State Dynamics

Christoph Weigel, Esko Kautto, Elshafa H. Ahmed, Yue-Zhong Wu, Charles T. Gregory, Ada C. Cleary, Sarah Y. Schlotter, Eric Brooks, Mark Lustberg, Robert A. Baiocchi, James S. Blachly, Christopher C. Oakes
Journal: Blood
Blood (2022) 140 (Supplement 1): 8772–8773.
https://doi.org/10.1182/blood-2022-159739
Published: 2022
Journal Articles

A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma.

Beth Christian, MD, Lapo Alinari, MD, Christian Tyler Earl, Emily Wilding, Carl Quinion, Mark Lustberg, MD, PhD, Don M Benson, Jr., MD, PhD, Jeffrey A. Jones, MD, MPH, John C. Byrd, MD, William A. Wegener, MD, PhD, David M. Goldenberg, ScD, MD, Robert A. Baiocchi, MD, PhD, Kristie A. Blum, MD
Journal: Blood
Blood (2010) 116 (21): 2788.
https://doi.org/10.1182/blood.V116.21.2788.2788
Published: 2010